Donenberg Phillip B.
SEC-identified person · CIK 1238120 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Sensei Biotherapeutics, Inc. SNSE | Director | filed 2026 - 2026 |
| Tectonic Therapeutic, Inc. TECX | Director | filed 2018 - 2026 |
| Taysha Gene Therapies, Inc. TSHA | Director | filed 2020 - 2026 |
| Depomed INC DEPO | SVP and CFO | filed 2018 - 2018 |
| Avexis, Inc. AVXS | Chief Financial Officer | filed 2017 - 2018 |
| Stratus Media Group, Inc SMDID | Director · Chief Financial Officer | filed 2014 - 2014 |
| Biosante Pharmaceuticals INC bpax | Sr. VP of Finance, CFO & Secy | filed 2006 - 2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.